Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023)

Avalo Therapeutics' Inventory Average history spans 6 years, with the latest figure at $18500.0 for Q2 2023.

  • For Q2 2023, Inventory Average fell 22.92% year-over-year to $18500.0; the TTM value through Jun 2023 reached $18500.0, down 22.92%, while the annual FY2022 figure was $29000.0, 41.46% up from the prior year.
  • Inventory Average reached $18500.0 in Q2 2023 per AVTX's latest filing, down from $19500.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $682452.5 in Q1 2019 to a low of $6030.0 in Q4 2020.
  • Average Inventory Average over 5 years is $80425.1, with a median of $20250.0 recorded in 2022.
  • Peak YoY movement for Inventory Average: plummeted 97.24% in 2020, then soared 347.76% in 2021.
  • A 5-year view of Inventory Average shows it stood at $211800.5 in 2019, then plummeted by 97.15% to $6030.0 in 2020, then skyrocketed by 347.76% to $27000.0 in 2021, then dropped by 22.22% to $21000.0 in 2022, then decreased by 11.9% to $18500.0 in 2023.
  • Per Business Quant, the three most recent readings for AVTX's Inventory Average are $18500.0 (Q2 2023), $19500.0 (Q1 2023), and $21000.0 (Q4 2022).